July 9, 2026

195: Rocky Batzel: "What It Means To Be Ready For Manufacturing At One Million Units Per Month"

Show Notes

Rocky Batzel, inventor and CEO of Snapslide, shares how a decade of tinkering became a child-resistant pill bottle closure designed for one hand and for people with arthritis or other limitations. From the original “aha” at a liquor store to prototyping, patents, and certification testing, Rocky explains the path to commercial viability and what scaling manufacturing for over a million units per month means next.

👤 About the Guest

Rocky Batzel is the inventor and CEO of Snapslide. He left medical school and built a career around product invention, focusing on tangible solutions. Snapslide creates a new approach to child-resistant openings for medication containers, aiming for accessibility without sacrificing safety requirements.

🧭 Conversation Highlights

Snapslide’s core idea: replacing torque-dependent bottle caps with a linear, two-stage opening that can be done with limited dexterity
How Rocky shifted from identifying everyday “pain in the butt” problems to searching for prior art, patents, and manufacturability
The business and regulatory gauntlet: child-resistant testing, USP permeation testing, iterative tooling, and certification timelines
How the team is preparing to scale manufacturing and capacity for large pharmacy distribution while continuing to develop OTC variants

💡 Key Takeaways

Accessibility is not a “nice to have.” It is a design constraint that must be baked into safety products from the start.
Great invention is less about finding a new problem and more about observing a familiar problem from a different angle.
Commercial success requires solving for manufacturability, cost, certification, and distribution incentives, not just the mechanism.
Scaling is a timing problem: tooling lead times, capital planning, and facility growth capacity have to align with demand.

❓ Questions That Mattered

What is Snapslide, and what design change makes it usable for one hand or limited dexterity while staying child-resistant?
How do you validate an idea when it is hard to know if you are truly first, or if prior art exists?
What does the child-resistant certification process actually require, including pass thresholds and sample counts?
What keeps you from taking profitable but misaligned deals, and how do you decide what is “worth it”?

🗣️ Notable Quotes